Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 178 participants.
Also called NCT07909915
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 178 participants
- Sponsor
- Rehman Medical Institute - RMI
- Registry
-
NCT07909915
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07909915. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease
- Condition
- Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
- Condition
- Stroke (CVA) or TIA (transient ischemic attack)
- Condition
- Cardio Vascular Disease
- Intervention (Drug)
- Dose adjustment of statins
- Intervention (Drug)
- no dose adjustment
- Lead sponsor
- Rehman Medical Institute - RMI
Record details
- Record id
cardio:ct-nct07909915- Content hash
f5aed13ea2ac0e33c72b9172b7f9ff497e523c27162db1747041e9a37669d7dc